Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-052021
Filing Date
2013-10-02
Accepted
2013-10-02 16:32:24
Documents
1
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd391945.html 4  
1 FORM 4 rrd391945.xml 4 8180
  Complete submission text file 0001181431-13-052021.txt   10302
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Associates GP LLC (Reporting) CIK: 0001290166 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33095 | Film No.: 131130671

Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 87 MARY STREET GEORGE TOWN GRAND CAYMAN E9 KY1-9005 2127056229
QVT Fund V LP (Reporting) CIK: 0001543904 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33095 | Film No.: 131130670